Looking beyond the CRT paradigm: Why induction chemotherapy is worthy of pursuit

Douglas Adkins; Jessica Ley; Loren Michel; Tanya M. Wildes; Wade Thorstad; Jason Rich; Brian Nussenbaum

doi:10.1016/j.oraloncology.2014.11.018

Looking beyond the CRT paradigm: Why induction chemotherapy is worthy of pursuit

Douglas Adkins, Jessica Ley, Loren Michel, Tanya M. Wildes, Wade Thorstad, Jason Rich, Brian Nussenbaum

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	103-104
Number of pages	2
Journal	Oral Oncology
Volume	51
Issue number	2
DOIs	https://doi.org/10.1016/j.oraloncology.2014.11.018
State	Published - 2015

Access to Document

10.1016/j.oraloncology.2014.11.018

Cite this

@article{64bc4f14f81a4a7f9f2c59ddfd89137a,

title = "Looking beyond the CRT paradigm: Why induction chemotherapy is worthy of pursuit",

author = "Douglas Adkins and Jessica Ley and Loren Michel and Wildes, {Tanya M.} and Wade Thorstad and Jason Rich and Brian Nussenbaum",

note = "Funding Information: Dr. Adkins has received research funding from Celgene. Funding Information: Dr. Wildes{\textquoteright} research is supported by Grant Number 1K12CA167540 through the NCI at the NIH and Grant Number UL1TR000448 through the CTSA program of the NCATS at the NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCI, NCATS, or NIH. ",

year = "2015",

doi = "10.1016/j.oraloncology.2014.11.018",

language = "English",

volume = "51",

pages = "103--104",

journal = "Oral Oncology",

issn = "1368-8375",

number = "2",

}

TY - JOUR

T1 - Looking beyond the CRT paradigm

T2 - Why induction chemotherapy is worthy of pursuit

AU - Adkins, Douglas

AU - Ley, Jessica

AU - Michel, Loren

AU - Wildes, Tanya M.

AU - Thorstad, Wade

AU - Rich, Jason

AU - Nussenbaum, Brian

N1 - Funding Information: Dr. Adkins has received research funding from Celgene. Funding Information: Dr. Wildes’ research is supported by Grant Number 1K12CA167540 through the NCI at the NIH and Grant Number UL1TR000448 through the CTSA program of the NCATS at the NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCI, NCATS, or NIH.

PY - 2015

Y1 - 2015

UR - http://www.scopus.com/inward/record.url?scp=84922592129&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2014.11.018

DO - 10.1016/j.oraloncology.2014.11.018

M3 - Editorial

C2 - 25497105

AN - SCOPUS:84922592129

SN - 1368-8375

VL - 51

SP - 103

EP - 104

JO - Oral Oncology

JF - Oral Oncology

IS - 2

ER -

Looking beyond the CRT paradigm: Why induction chemotherapy is worthy of pursuit

Access to Document

Other files and links

Cite this